February 2021 - Page 34 of 38

WednesdayFeb 03, 2021 11:03 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Signs Production Agreement with Applied Pharmaceutical Innovation

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, announced that it has signed an agreement with Applied Pharmaceutical Innovation. A not-for-profit institution at the University of Alberta, Applied supports translational drug development for industry and innovators. XPhyto’s psychedelic pharmaceutical production agreement calls for the synthesis of pharmaceutical-grade psychedelic compounds and the development of the standard operating procedures required to obtain regulatory approval for the commercial production process. As part of its psychedelic pharmaceutical program, XPhyto needs industrial-scale production of standardized active pharmaceutical ingredients. This agreement is part of that strategic…

WednesdayFeb 03, 2021 10:39 am

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Completes New Company Registration for Class 1 NPN

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company specializing in cannabis, hemp and mushroom products, announced that it has completed its application for new company registration with the Natural and Non-prescription Health Products Directorate (“NNHPD”) and subsequently has received its company code. As a result, Pure Extracts can now submit an application for a Class 1 Natural Product Number (“NPN”) for a functional mushroom product. PULL anticipates this will be the first of several NPN applications it submits in 2021. The applications are part of Pure Extracts strategic plan to sell functional mushroom wellness products through…

WednesdayFeb 03, 2021 10:39 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB:8OO) Announces US Symbol

HempFusion Wellness (TSX: CBD.U), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, announced that it has secured its OTC Markets trading symbol, “CBDHF,” allowing a broader U.S. investor audience the ability to trade shares in the company. “As a U.S.-based CBD company, this important step allows a broader range of U.S. investors to access the company,” said Jason Mitchell N.D., HempFusion’s co-founder and CEO. “Additionally, we have applied for an OTCQX listing and DTC eligibility, which we expect in the coming weeks subject to the approval of the OTCQX and the satisfaction of certain…

WednesdayFeb 03, 2021 10:21 am

QualityStocksNewsBreaks – Recruiter.com Group Inc. (RCRT) Announces Acquisition of Video-based Candidate Insight Platform

Recruiter.com Group Inc. (OTCQB: RCRT), an on-demand video-enabled and artificial intelligence hiring platform with the world's largest network of recruiters, has acquired Scouted.io. Scouted is a venture capital-backed tech start-up that is committed to developing deep insights into candidates using video screening and AI-based scoring algorithms. The acquisition was finalized on Jan. 31, 2021, and comprised an asset purchase agreement, with Recruiter.com completing the acquisition primarily with payment of restricted common stock. The announcement notes that Scouted CEO and cofounder Jacqueline Loeb will serve as senior vice president at Recruiter.com. The acquisition supports and strengthens Recruiter.com’s mission of becoming a top-of-mind hiring…

WednesdayFeb 03, 2021 10:09 am

QualityStocksNewsBreaks – Predictive Oncology (NASDAQ: POAI) Announces Regained Compliance with Nasdaq’s Minimum Bid Price Requirement

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has received a letter from the Listing Qualifications Department of the Nasdaq Stock Market Inc. (NASDAQ). The letter informed Predictive Oncology that the company had regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the exchange’s listing rules. In October 2020, POAI had been notified by NASDAQ that it no longer met the organization’s minimum price bid requirement because it’s closing bid price per share had been below $1 for a period of 30 consecutive business…

WednesdayFeb 03, 2021 9:34 am

QualityStocksNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Announces Agreement with CROSSMARK, Could Include 100,000+ Points of Sale

TAAT(TM) Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRA: 2TP2), a life sciences company dedicated to giving legal-aged smokers the choice to keep the smoking experience that they enjoy with no nicotine and no tobacco, has announced that its flagship product will be represented by CROSSMARK Inc. CROSSMARK is a Texas-based sales and marketing agency with more than 25,000 employees and proven success in commercializing tobacco alternatives. The company will be representing all three varieties of TAAT and will be intent on securing on-shelf retail availability at more than 100,000 convenience stores located throughout the United States. The agreement notes that,…

TuesdayFeb 02, 2021 3:31 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Is ‘One to Watch’

XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities The company has research and development operations in North America and Europe and an operational focus in Germany XPhyto’s operations are concentrated into three core divisions: infectious disease diagnostics, clinical development of transdermal and sublingual drug formulations, and psychedelic medicine The company’s lead diagnostic product is an accurate, rapid and highly portable PCR diagnostic test system being evaluated in Europe for the detection of COVID-19 XPhyto’s German subsidiary, Vektor Pharma TF GmbH, is advancing four therapeutic programs targeting neurological indications;…

TuesdayFeb 02, 2021 3:07 pm

Brain Scientific Inc. (BRSF) E-Tattoo Will Offer AI Solutions for Neurology

BRSF paving way with next wave of innovation for neurology: e-tattoos Acceptance of telemedicine, AI here to stay following pandemic Scientists have learned how to read brain waves using minimally invasive, implantable, four-channel micro EEG to better monitor continuous seizures The COVID-19 pandemic has accelerated several changes to American culture, many of which appear to be here to stay. According to Harvard experts, some of those changes include movement towards a cashless society, increased remote work, the decline of brick-and-mortar retail, and a new approach to health that includes an acceptance of telemedicine and artificial intelligence (“AI”) (https://ibn.fm/f9IJ5). Brain Scientific…

TuesdayFeb 02, 2021 2:54 pm

CannAssist International Corp. (CNSC) Proprietary Tech Is Core of CBD Products with Better Absorption

Absorption vital component of product effectiveness CNSC's proprietary CiBiDinol technology is cannabidiol made water compatible Xceptol products offer CBD in format more in line with body's natural bioactivity CannAssist International (OTCQB: CNSC) is a biotechnological pharmaceutical and wellness company marketing its exclusive Xceptol consumer brand. The company is the owner of Xceptor Labs, which uses proprietary technology to create Xceptol CBD products. The company complex has better absorption than currently marketed oil-based products — a key advantage when assessing products' effectiveness. Drug absorption, or the way a drug is absorbed into the bloodstream, is a vital component in the effectiveness…

TuesdayFeb 02, 2021 2:30 pm

QualityStocksNewsBreaks – Village Farms International Inc. (NASDAQ: VFF) (TSX: VFF) Secures US$135M in Registered Direct Offering

Village Farms International (NASDAQ: VFF) (TSX: VFF) has closed a sale of 10,887,097 common shares to certain institutional investors. According to the update, Village Farms secured approximately US$135 million (approximately CA$171 million) in gross proceeds, with each of the shares sold at the price of US$12.40 (approximately CA$15.70). The company intends to use the proceeds for general working capital purposes. ROTH Capital Partners acted as co-placement agent for the offering. To view the full press release, visit https://ibn.fm/18h2e About Village Farms International Inc. Village Farms is one of the largest and longest-operating greenhouse growers in North America, and is leveraging…

Site Search

Company Search

Month: February 2021